Pricing Log in Create free account

Cullinan Therapeutics, Inc. (CGEM) vs Savara Inc. (SVRA)

Cullinan Therapeutics, Inc. and Savara Inc. are both Biotechnology companies. Cullinan Therapeutics, Inc. and Savara Inc. are of similar size ($973.9M and $901.0M). Across the 10 metrics below, Cullinan Therapeutics, Inc. leads on 6 and Savara Inc. on 4.

Valuation

Metric CGEM SVRA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.47 7.85 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (23.98%) (13.03%) (33.15%)
Free cash flow yield (20.03%) (9.81%) (25.50%)

Profitability

Metric CGEM SVRA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.30%) (105.48%) (56.36%)
Return on assets (46.30%) (78.28%) (48.04%)
Return on invested capital 0.00% (12,213.18%) 0.00%

Growth

Metric CGEM SVRA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (20.86%) (10.42%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEM SVRA Biotechnology median
Debt to equity 0.00 0.21 0.00
Current ratio 8.42 10.13 4.72
Net debt to EBITDA 1.57 1.64 0.96

Dividend

Metric CGEM SVRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGEM SVRA Biotechnology median
Market cap 900.97m 973.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack